GILDvsREGN
Gilead Sciences IncvsRegeneron Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Gilead Sciences Inc
$133.64
+10.12%
Regeneron Pharmaceuticals Inc
$766.02
+3.34%
60-day price, rebased to 100
Round-by-round
Valuation upside
-27.50% vs -22.60% to DCF fair value
Balance-sheet strength
Altman Z 4.47 vs 7.40
Fundamental quality
Piotroski 8.00 vs 5.00 (of 9)
Growth + margins
Rule-of-40 34.50 vs 27.20
60-day momentum
-6.47% vs +1.98% price return
Market-cap liquidity
$173.4B vs $79.2B
Verdict
Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onGILDorREGN
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.